Rajendra Apte, M.D., Ph.D.
Dr. Apte is the Paul A. Cibis Distinguished Professor at Washington University School of Medicine in St. Louis, Missouri, where he serves as the Vice Chair of Innovation and Translation in the Department of Ophthalmology and Visual Sciences and is a Professor in the Department of Developmental Biology and Medicine.
Julie Ahringer, Ph.D.
Dr. Ahringer is a Professor of Genetics and Genomics at The Gurdon Institute, University of Cambridge. Her research focuses on the developmental regulation of chromatin structure and function.
Mr. Augustenborg is a founding advisor to Liberty Biosecurity. He recently completed a 35-year career in the CIA’s Clandestine Service, which included nine field assignments. Most recently, Lon headed the CIA’s largest domestic office, where he worked closely with the U.S. private sector.
Johan Auwerx, M.D., Ph.D.
Dr. Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he directs the Laboratory for Integrated and Systems Physiology (LISP). He has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease.
Ami Bhatt, M.D., Ph.D.
Dr. Bhatt is an Assistant Professor of Medicine & Genetics at Stanford University. She received her M.D. and Ph.D. in Biochemistry & Molecular Biology at UCSF. There she received the Fineberg Award for Excellence in Teaching and was inducted into Alpha Omega Alpha.
Joseph is currently Chief Executive Officer of LunaPBC, manager of Luna DNA, a health data platform uniting people, communities, and researchers. Mr. Beery is an experienced leader of corporate information technology (“IT”) systems with a long history in managing IT and eCommerce services for global companies.
Ewan Birney, Ph.D.
Dr. Birney is Director of EMBL-EBI, the European Molecular Biology Laboratory — European Bioinformatics Institute. He led the analysis group for the ENCODE project, which is defining functional elements in the human genome.
Esther Babady, Ph.D.
Dr. Babady is the Section Head, Clinical Microbiology Service Director, Clinical Microbiology Fellowship Program, Attending Microbiologist, Clinical Microbiology and Infectious Disease Services Member (Professor), Departments of Laboratory Medicine and Medicine at Memorial Sloan Kettering Cancer Center.
Judith Breuer, M.D.
Dr. Breuer is Professor of Virology and Director of Pathogen Genomics Unit at the University College London. She simultaneously holds a clinical position at Great Ormand Street Hospital. Her research focuses on genome sequencing and phylogentics and includes the development of new tools and tests to protect people from antimicrobial resistance.
Carlos D. Bustamante, Ph.D.
Dr. Bustamante is an internationally recognized leader in the application of data science and genomics technology to problems in medicine, agriculture, and biology. He is Founding Director of the Stanford Center for Computational, Evolutionary, and Human Genomics (CEHG) and Inaugural Chair of the Department of Biomedical Data Science.
Carlos Bustamante, MD
Dr. Bustamante is a Clinical Professor at Florida International University and in private practice of infectious disease at Aventura Hospital Medical Center, Jackson Medical Hospital – North, and North Shore Medical Center, Miami Florida.
Susan Butler-Wu, Ph.D.
Dr. Butler-Wu is the Director of Clinical Microbiology at LAC+USC Medical Center and an Associate Professor of Clinical Pathology at the Keck School of Medicine of USC. Dr Butler-Wu earner her PhD in Molecular Microbiology at Tufts University and completed her postdoctoral fellowship in Tuberculosis Pathogenesis at New York University.
Arul Chinnaiyam, M.D., Ph.D.
Arul M. Chinnaiyan, M.D., Ph.D. is a Howard Hughes Medical Institute Investigator, American Cancer Society Research Professor, and S.P. Hicks Endowed Professor of Pathology and Urology at the University of Michigan. He also serves as the inaugural Director of the Michigan Center for Translational Pathology (MCTP).
James Cole, J.D.
Mr. Cole, former Deputy Attorney General of the United States, is a global co-lead of the White Collar: Government Litigation and Investigations practice. His practice includes the full range of federal enforcement and internal investigation matters, with a particular emphasis on cross-border and multi-jurisdictional matters.
David Deamer, Ph.D.
Dr Deamer is a Research Professor of Biomolecular Engineering at the University of California, Santa Cruz. Dr. Deamer has made significant contributions to the field of membrane biophysics. His work led to a novel method of DNA sequencing and a more complete understanding of the role of membranes in the origin of life.
Richard Durbin, Ph.D.
Dr. Durbin is the Al Kindi Professor in the Department of Genetics at the University of Cambridge. He was previously a Senior Group Leader and joint Head of Human Genetics at The Wellcome Trust Sanger Institute. He received a BA in Mathematics, and a Ph.D. in Biology from Cambridge University.
James Ellis, Ph.D.
Dr. Ellis has been the CSO at Nocion since July 2018. Most recently, he led GSK’s Innovation Hub in Cambridge after serving as Vice President and Head of GSK’s Sirtuin Discovery Performance Unit.
Yaniv Erlich, Ph.D.
Dr. Erlich is a Core Member at the New York Genome Center and Associate Professor of Computer Science and Computational Biology at Columbia University. Prior to these positions, Yaniv was a Principal Investigator at the Whitehead Institute, MIT.
Neil Flanzraich, J.D.
Mr. Flanzraich is the Executive Chairman of Cantex Pharmaceuticals, Inc. a biotech company developing novel therapies for cancer. He is the Lead Independent Director of the Board of Directors of Chipotle Mexican Grill, Inc. (CMG:NYSE), a chain of casual fast-food restaurants and the Executive Chairman of Alzheon, Inc. a biotech developing a novel therapeutic for Alzheimer’s Disease.
Mr. Geurts is a retired United States Air Forces colonel who most recent served ast the United State Under Secretary of the Navy. He had previously served as Assistant Secretary of the Navy (Research, Development and Acquisition) and Senior Executive Service as acquisition executive for the United States Special Operations Command.
Richard “Ed” Green, Ph.D.
Dr. Green is an Assistant Professor of biomolecular engineering, Baskin School of Engineering, UC Santa Cruz. he is a Founding Advisor to Dovetail Genomics, Arc Bio, and Claret. He earned his Ph.D. from the University of California, Berkeley in 2005. Ed’s advisor was Steven Brenner with whom he co-authored 14 papers on a wide variety of computational biology subjects.
David Haussler, Ph.D.
Dr. Haussler is the Distinguished Professor of Biomolecular Engineering at the University of California, Santa Cruz, and scientific director of the UC Santa Cruz Genomics Institute. David is an Investigator at the Howard Hughes Medical Institute, cofounder of the Genome 10K Project, and scientific co-director of the California Institute for Quantitative Biosciences (QB3), UC Santa Cruz.
Nicholas Hud, Ph.D.
Dr. Hud is currently a Regents Professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology. He received his B.S. degree from Loyola Marymount University. His Ph.D. was conferred by the University of California, Davis for physical investigations of DNA condensation by protamine.
Franz Humer, Ph.D.
Dr. Humer is currently a Venture Partner and Senior Advisor at Pappas Capital, reuniting with Art Pappas and Ernie Mario, who all served together in the early 1990s as senior executives and board members for Glaxo Holdings. In March 2014, Franz retired as Chairman of Roche Holding Ltd., capping a transformative 15-year tenure as Chairman and/or Chief Executive Officer.
Paul Keim, Ph.D.
Dr. Keim is the Cowden Endowed Chair of Microbiology at Northern Arizona University (NAU), the Director of Pathogen Genomics at the Translational Genomics Research Institute (TGen) and research affiliate at Los Alamos National Laboratory (LANL). He has been faculty member at NAU since 1988 after postdoctoral studies at the University of Utah and Iowa State University.
Nick Lane, Ph.D.
Dr. Lane is a Professor of Evolutionary Biochemistry at University College of London. Educated at Imperial College, London, he earned his PhD at the Royal Free Hospital Medical School in 1995 with a thesis entitled In vivo studies of ischemia-reperfusion injury in hypo-thermically stored rabbit renal autograft.
Until recently, Ms. Lord served as the first Under Secretary of Defense for Acquisition and Sustainment (A&S), leading the Department of Defense’s personnel, policies and processes involved in Pentagon acquisition, contracts, logistics, and the defense industrial base.
Christopher Mason, Ph.D.
Dr. Mason is Professor of Physiology and Biophysics at the Weill Cornell School of Medicine. Dr. Mason is also the Director of WorldQuant Initiative for Quantitative President and WorldQuant Foundation Research Scholar. In addition, Dr. Mason is a Professor of Computational Genomics in Computational Biomedicine as well as Professor of Neuroscience in the Brain and Mind Institute.
Steven McCarroll, Ph.D.
Dr. McCarroll is the Dorothy and Milton Flier Professor of Biomedical Science at Harvard Medical School and the Director of Genetics for the Broad Institute’s Stanley Center for Psychiatric Research and assistant professor in Harvard Medical School’s Department of Genetics.
Siddhartha Mukerjee, Ph.D., M.D.
Dr. Mukerjee is a Board-Certified physician in Hemotology and Medical Oncology as well as an Assistant Professor of Medicine at Columbia University Irving Medical Center. Dr, Mukerjee holds a BS in biology from Stanford University, a DPhil in immunology from Oxford University (where he was a Rhodes Scholar), and an MD from Harvard Medical School.
Aristides Patrinos, Ph.D.
Dr. Patrinos is a global authority on structural biology, genomics, and global environmental change. Ari was previously Deputy Director, Research, NYU Center for Urban Science & Progress, Brooklyn, NY. Prior to that, he was President of Synthetic Genomics Inc., and Director of the Office of Biological and Environmental Research in the Department of Energy’s Office of Science, where he oversaw human and microbial genome research, structural biology, nuclear medicine and health effects and global climate change.
Eric Peterson, M.D.
A recognized world leader in clinical research with more than 1400 peer-reviewed publications, Dr. Peterson is the Adelyn and Edmund M. Hoffman Distinguished Professor of Medicine, Vice Provost & Senior Associate Dean for Clinical Research & Vice President for Health System Research at UT Southwestern Medical Center. Dr. Peterson is formally from Duke University Medical Center where he was a distinguished professor and prior Executive Director of the Duke Clinical Research Institute (DCRI).
Martin Powers, M.D.
Dr. Powers is a self-described molecular genomic pathologist with a passion for the clinical applications of molecular biology. Before joining UCSD, Martin served for three years directing the clinical molecular oncology efforts for the University of California, San Francisco clinical labs, where he was also an assistant clinical professor.
US Navy Vice Admiral (ret)
Mr. Pybus is a retired United States Navy Vice Admiral who last served as the deputy Commander, US Special Operations Command. He previously served as a vice admiral assigned to the Nato Special Operations Headquarters in Belgium and as the Commander, Naval Special Warfare Command in Coronado, California.
David Relman, M.D.
Dr. Relman is the Thomas C. and Joan M. Merigan Professor in Medicine, and a Professor of Microbiology & Immunology at Stanford University, and Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System. He is also Senior Fellow at the Center for International Security and Cooperation at Stanford. David trained at MIT and then Harvard Medical School, followed by clinical training in internal medicine and infectious diseases at the Massachusetts General Hospital in Boston, and a postdoctoral fellowship in microbiology at Stanford.
Dan Rokhsar, Ph.D.
Dr. Rokhsar is a founding member of the Dovetail Genomics SAB. He has been the faculty at the University of California-Berkeley since 1989, when he joined the Physics department. In 2002 he joined the genetics faculty after his research interests shifted to computational biology, genomics and evolution. He leads the Berkeley Training Program in Computational and Genomic Biology.
Juan Santiago, Ph.D.
Dr. Santiago is a Professor of Mechanical Engineering at Stanford. He received his MS and Ph.D. in Mechanical Engineering from the University of Illinois at Urbana-Champaign in 1995. His research includes the development of microsystems for on-chip chemical and biochemical analysis, methods for sample preparation, miniature pumps, and electric-field based deionization methods.
Anthony Sauve, Ph.D.
Dr. Sauve is Associate Professor of Pharmacology, Weill Cornell Med. Coll., Ph.D., Princeton. He is a founding SAB member of MetroBiotech. Anthony has spent the last 20 years of his academic career as a post-doctoral as well as a faculty investigator studying NAD+ biosynthetic pathways, NAD+ precursors and enzymes (e.g., sirtuins, CD38) that utilize NAD+ as a substrate.
Nadim Shaath, Ph.D.
Dr. Nadim Shaath is the founder of Alpha Research & Development, Ltd., and is currently its President. Alpha R&D, Ltd. is a research and sourcing company of essential oils, absolutes, resinoids and therapeutic ingredients. He is the editor of several books on Sunscreens including Sunscreens published by Marcel Dekker and is the author of the book entitled The Encyclopedia of Ultraviolet Filters, published by Allured.
Beth Shapiro, Ph.D.
Since 2012, Dr. Shapiro has been affiliated with the University of California at Santa Cruz, where she is currently associate director of the Genomics Institute, co-director of the Paleogenomics Lab, and professor in the Department of Ecology and Evolutionary Biology. She has been named a HHMI Investigator (2018), National Geographic Emerging Explorer (2010), a Packard Fellow (2010), and a Searle Scholar (2009).
Mr. Slezak has spent more than three decades in the bioinformatics field. Tom first came to Lawrence Livermore National Laboratories (LLNL) as a summer student in 1974, joining their Bio-Med Program as a full-time computer scientist in 1978. He eventually went on to work on the Human Genome Project, pioneering the use of what came to be called “bioinformatics” in DNA physical mapping, and was part of the team that built the Joint Genome Institute in Walnut Creek.
Li-Huei Tsai, Ph.D.
Dr. Tsai is Director and Picower Professor of Neuroscience at MIT’s Picower Institute for Learning and Memory, as well as the Department of Brain and Cognitive Sciences. She is an expert in the pathogenesis of neuro disorders that impact cognition and memory. Li-Huei’s lab has studied Alzheimer’s Disease and Tau pathologies in humans and in mice, including the role of neuronal networks, neurodegeneration, and targeted genetic approaches and gamma circuit oscillations as potential treatments.
Lindsay Wu, Ph.D.
Dr. Wu is a Senior Research Fellow at University of New South Wales in Syndey, Australia in Medicine and Health. He heads the Laboratory for Ageing Research at UNSW where they seek to understand the molecular process of biological ageing, with applications of these findings to physiologically relevant processes such as reproductive ageing.